Reneo Pharmaceuticals (RPHM) - Net earnings per share (EPS TTM)

Symbol and logo of brand reneopharma.com (RPHM)

Reneo Pharmaceuticals (RPHM) effectively terminated its previous research due to failures in final testing, resorting to a merger to salvage its assets. GURU.Markets data is displayed on this chart, where the fundamental EPS TTM metric reflects current trends, and the indicator value reaches -1.70. The company is currently focusing on developing treatments for rare mitochondrial pathologies. Such orphan medicine is entirely non-cyclical and maximally resilient to macroeconomic shocks.

RPHM (reneopharma.com) Earnings per share for the last 12 months history from 07/04/2022 to 10/07/2024

Comprehensive metric breakdowns and analytics for Reneo Pharma (RPHM)

General company analysis:reneopharma.com (RPHM)
Mass-produced product of Reneo Pharmaceuticals Inc.

Annual net earnings per share reflects the actual portion of income attributable to a single security. By analyzing the trend of the rolling annual EPS, an investor determines the fundamental value of the asset without market noise. The metric is calculated as the ratio of final profit to the number of shares, remaining sensitive to one-off transactions. Historical extremes help avoid buying at the peak. The stability of this indicator for Reneo Pharmaceuticals (RPHM) is supported by the optimization of chemical compound supplies, which eliminates downtime in drug development.

Competitors of Reneo Pharmaceuticals (RPHM)

VRTX: Net earnings per share for the last 12 months|Earnings per one share for the last 12 months ALNY|INSM: Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months United Therapeutics Corp. (UTHR)|BMRN (BioMarin) - Net earnings per share (EPS TTM)|Earnings per share for the last 12 months BBIO (BridgeBio)|Earnings per share for the last twelve months bgm.ltd (BGM)|COGT (Cogent Biosciences Inc) - Earnings per share for the trailing year|Earnings per share for the last twelve months Xeris Biopharma Holdings XERS|KROS (Keros Pharma) - Earnings per one share for the last 12 months|Arcturus Therapeutics - Net earnings per share (EPS TTM)|Earnings per share for the trailing year ETON (Eton Pharmaceuticals)|KMDA: Net earnings per share (EPS TTM)|Fulcrum Therapeutics Inc (FULC) - Net earnings per share (EPS TTM)|Earnings per share for the last twelve months abeonatherapeutics.com|MREO: Earnings per share for the trailing year|Net earnings per share (EPS TTM) PLX|Net earnings per share for the last 12 months Pliant Therapeutics, Inc. PLRX|Net earnings per share (EPS TTM) APLT (Applied Therapeutics Inc.)|Net earnings per share (EPS TTM) Rein Therapeutics Inc. RNTX|gelteq.com - Net earnings per share (EPS TTM)|AYTU - Net earnings per share (EPS TTM)|CMMB: Net earnings per share (EPS TTM)|SRx Health Solutions Inc. - Earnings per share for the trailing year|Earnings per share for the last twelve months Polyrizon Ltd|AEZS (Aeterna Zentaris) - Earnings per share for the last four quarters|Earnings per share for the last twelve months CTD Holdings (CYTH)|INZY: Earnings per one share for the last 12 months|Net earnings per share (EPS TTM) CSCI (cosciensbio.com)